Drugs / Colloidal silver nanoparticles
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03243201 | Jan → Dec 2018 | chronic rhinosinusitis | Washington University School of Medicine | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Colloidal silver nanoparticles | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03243201 ↗ |
| Route | Intranasal | “The colloidal silver arm will administer intranasal colloidal silver, 2 sprays each nostril twice daily” NCT03243201 ↗ |